1. Home
  2. DRMA vs BAOS Comparison

DRMA vs BAOS Comparison

Compare DRMA & BAOS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • DRMA
  • BAOS
  • Stock Information
  • Founded
  • DRMA 2014
  • BAOS 2018
  • Country
  • DRMA United States
  • BAOS China
  • Employees
  • DRMA N/A
  • BAOS N/A
  • Industry
  • DRMA Biotechnology: Pharmaceutical Preparations
  • BAOS Business Services
  • Sector
  • DRMA Health Care
  • BAOS Consumer Discretionary
  • Exchange
  • DRMA Nasdaq
  • BAOS Nasdaq
  • Market Cap
  • DRMA 3.6M
  • BAOS 4.2M
  • IPO Year
  • DRMA 2021
  • BAOS 2021
  • Fundamental
  • Price
  • DRMA $5.57
  • BAOS $3.05
  • Analyst Decision
  • DRMA Strong Buy
  • BAOS
  • Analyst Count
  • DRMA 1
  • BAOS 0
  • Target Price
  • DRMA $10.00
  • BAOS N/A
  • AVG Volume (30 Days)
  • DRMA 27.3K
  • BAOS 1.7M
  • Earning Date
  • DRMA 08-13-2025
  • BAOS 09-26-2025
  • Dividend Yield
  • DRMA N/A
  • BAOS N/A
  • EPS Growth
  • DRMA N/A
  • BAOS N/A
  • EPS
  • DRMA N/A
  • BAOS N/A
  • Revenue
  • DRMA N/A
  • BAOS $624,087.00
  • Revenue This Year
  • DRMA N/A
  • BAOS N/A
  • Revenue Next Year
  • DRMA N/A
  • BAOS N/A
  • P/E Ratio
  • DRMA N/A
  • BAOS N/A
  • Revenue Growth
  • DRMA N/A
  • BAOS N/A
  • 52 Week Low
  • DRMA $5.04
  • BAOS $1.44
  • 52 Week High
  • DRMA $24.90
  • BAOS $13.66
  • Technical
  • Relative Strength Index (RSI)
  • DRMA 45.37
  • BAOS 55.74
  • Support Level
  • DRMA $5.04
  • BAOS $2.84
  • Resistance Level
  • DRMA $5.74
  • BAOS $3.23
  • Average True Range (ATR)
  • DRMA 0.39
  • BAOS 0.49
  • MACD
  • DRMA 0.03
  • BAOS 0.03
  • Stochastic Oscillator
  • DRMA 48.91
  • BAOS 16.07

About DRMA Dermata Therapeutics Inc.

Dermata Therapeutics Inc is a late-stage medical dermatology company focused on identifying, developing, and commercializing pharmaceutical product candidates for the treatment of medical skin diseases and aesthetic applications. Its two product candidates, XYNGARI (formerly known as DMT310) and DMT410, incorporate its proprietary, multifaceted, Spongilla technology to topically treat a variety of dermatological conditions. Its Spongilla technology platform will enable to development and formulation of singular and combination products that can target topical delivery of chemical compounds into the dermis for maximum treatment effect for a variety of inflammatory skin diseases. Dermata announced positive Phase 3 data from its STAR-1 clinical trial in March 2025.

About BAOS Baosheng Media Group Holdings

Baosheng Media Group Holdings Ltd operates as a V-log streaming marketing service provider. The firm offers comprehensive marketing solutions. Its services are Internet effect marketing, V-log or short video streaming marketing including content production and operation, e-commerce marketing, original data platform system service, and AI technology. It provides one-stop and full-link deep customized marketing solutions for partners. Baosheng Group is also a core agency of domestic Internet companies such as Tencent, Alibaba, Bytedance, and Kuaishou, with performing channel marketing services, technologies, and applications.

Share on Social Networks: